Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Report 2026
Global Outlook – By Product Type (Ribonucleic Acid Isolation Kits, Ribonucleic Acid Enrichment Kits), By Sample Type (Blood Samples, Tissue Samples, Cell Samples, Microorganism Samples, Other Sample Types), By Price Range (Entry Level Less Than Two Hundred Dollars, Mid Range Two Hundred Dollars To Five Hundred Dollars), By Application (Research, Diagnostics, Therapeutics), By End User (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals) – Market Size, Trends, Strategies, and Forecast to 2030
Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Report 2026 Market Overview
• Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Report 2026 market size has reached to $0.94 billion in 2025 • Expected to grow to $1.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Increasing Genomics Research Activities Fueling The Growth Of The Market Due To Rising Demand For Precision Medicine And Gene-Based Therapies • Market Trend: Rapid One-Step Viral RNA Extraction Technologies Enhance Molecular Diagnostic Efficiency For Infectious Disease Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market?
A ribonucleic acid (RNA) isolation and enrichment reagents are specialized chemical solutions and kits used to extract, purify, and concentrate RNA molecules from biological samples such as tissues, cells, and blood. These reagents help preserve RNA integrity while removing contaminants including proteins, DNA, and other cellular materials. A ribonucleic acid (RNA) isolation and enrichment reagents are widely used in molecular biology and diagnostic workflows to enable accurate gene expression analysis, sequencing, and other RNA-based research applications. The main product types of ribonucleic acid (RNA) isolation and enrichment reagent include ribonucleic acid isolation kits and ribonucleic acid enrichment kits. Ribonucleic acid isolation kits refer to products designed to isolate and purify RNA from biological samples for research and diagnostic purposes. These products are designed for sample types including blood samples, tissue samples, cell samples, microorganism samples, and other sample types and are available in price ranges including entry level less than two hundred dollars and mid range two hundred dollars to five hundred dollars. The various applications involved are research, diagnostics, and therapeutics and they are utilized by end users including academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and hospitals.
What Is The Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Size and Share 2026?
The ribonucleic acid (RNA) isolation and enrichment reagent market size has grown rapidly in recent years. It will grow from $0.94 billion in 2025 to $1.04 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to rising demand for molecular diagnostics in infectious diseases, increasing adoption of next generation sequencing technologies, growth in academic and clinical genomics research funding, expansion of biobanking and sample preservation infrastructure, early adoption of manual rna extraction methods in laboratories.What Is The Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Growth Forecast?
The ribonucleic acid (RNA) isolation and enrichment reagent market size is expected to see rapid growth in the next few years. It will grow to $1.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing shift toward automated and high throughput rna isolation systems, rising demand for precision medicine and transcriptomics based drug discovery, growing use of AI driven bioinformatics for rna data interpretation, expansion of personalized medicine and rare disease research programs, increasing integration of lab robotics and digital lab ecosystems. Major trends in the forecast period include increasing adoption of automated rna extraction platforms integrated with laboratory robotics, growing demand for high purity rna isolation kits for next generation sequencing workflows, expansion of low input and single cell rna isolation solutions for advanced genomics research, rising use of magnetic bead based purification technologies for improved yield and scalability, increasing integration of cloud connected laboratory informatics systems for rna workflow optimization.
Global Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Segmentation
1) By Product Type: Ribonucleic Acid Isolation Kits, Ribonucleic Acid Enrichment Kits 2) By Sample Type: Blood Samples, Tissue Samples, Cell Samples, Microorganism Samples, Other Sample Types 3) By Price Range: Entry Level Less Than Two Hundred Dollars, Mid Range Two Hundred Dollars To Five Hundred Dollars 4) By Application: Research, Diagnostics, Therapeutics 5) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals Subsegments: 1) By Ribonucleic Acid Isolation Kits: Total Ribonucleic Acid Isolation Kits, Messenger Ribonucleic Acid Isolation Kits, Micro Ribonucleic Acid Isolation Kits, Small Ribonucleic Acid Isolation Kits, Viral Ribonucleic Acid Isolation Kits, Cell Free Ribonucleic Acid Isolation Kits, Tissue Ribonucleic Acid Isolation Kits, Blood Ribonucleic Acid Isolation Kits, Plant Ribonucleic Acid Isolation Kits, Bacterial Ribonucleic Acid Isolation Kits 2) By Ribonucleic Acid Enrichment Kits: Polyadenylated Messenger Ribonucleic Acid Enrichment Kits, Ribosomal Ribonucleic Acid Depletion Kits, Small Ribonucleic Acid Enrichment Kits, Micro Ribonucleic Acid Enrichment Kits, Long Non Coding Ribonucleic Acid Enrichment Kits, Circular Ribonucleic Acid Enrichment Kits, Exosomal Ribonucleic Acid Enrichment Kits, Targeted Transcript Enrichment Kits, Viral Ribonucleic Acid Enrichment Kits, Non Coding Ribonucleic Acid Enrichment KitsWhat Is The Driver Of The Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market?
The increasing genomics research activities are expected to propel the growth of the ribonucleic acid (RNA) isolation and enrichment reagent market going forward. Genomics research activities refer to the increasing scientific studies involving gene sequencing, transcriptomics, RNA analysis, and molecular biology investigations. Genomics research activities are increasing due to the rising demand for precision medicine, which requires detailed analysis of genetic information to develop targeted therapies and personalized treatment approaches. Ribonucleic acid (RNA) isolation and enrichment reagent supports genomics research activities by enabling the extraction and purification of high-quality RNA for sequencing, transcriptomics, and gene expression analysis, improving data accuracy and the reliability of downstream molecular research. For instance, in July 2023, according to a report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of the first quarter (Q1) 2023, there were 247 gene therapies in Phase II, but this number rose by 5% to reach 260 by the end of the second quarter (Q2), reflecting growing genomics and genetic research activities. Therefore, the increasing genomics research activities are driving the growth of the ribonucleic acid (RNA) isolation and enrichment reagent industry.Key Players In The Global Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment reagent market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva Sweden AB, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., Tiangen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Illumina Inc., 10x Genomics Inc., Covaris LLC
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Trends and Insights
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment reagents market are focusing on developing one-step viral RNA extraction kits to improve diagnostic speed, accuracy, and workflow efficiency in infectious disease testing. One-step viral RNA extraction kits are specialized molecular diagnostic solutions designed to rapidly isolate high-quality nucleic acids from clinical samples while minimizing processing steps, contamination risks, and equipment requirements. For instance, in September 2025, Xpedite Diagnostics GmbH, a Germany-based biotechnology company, launched SwiftX Virus, a CE-IVD-certified one-step viral RNA extraction kit for human serum and plasma. It is designed for professional diagnostics and point-of-care applications. The kit delivers PCR-ready viral RNA and bacterial DNA in just six minutes using proprietary reverse purification technology, eliminating the need for centrifuges, spin columns, or hazardous solvents. The solution demonstrated 98% sensitivity and 100% specificity across multiple tropical and vector-borne pathogens, including Dengue, Chikungunya, Yellow Fever, West Nile Virus, and Leptospira, supporting faster and more reliable molecular diagnostics in clinical and outbreak-response settings.What Are Latest Mergers And Acquisitions In The Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market?
In January 2023, ALS Limited, an Australia-based testing laboratory company, acquired Invitek Molecular GmbH for an undisclosed amount. With this acquisition, ALS Limited aimed to strengthen its molecular diagnostics and life sciences capabilities, expand its sample preparation and nucleic acid extraction portfolio, and enhance its presence in the global biotechnology and clinical testing markets. Invitek Molecular GmbH is a Germany-based provider of nucleic acid isolation kits, molecular diagnostic reagents, sample preparation technologies, and automated purification solutions for research, clinical, and industrial applications.
Regional Outlook
North America was the largest region in the ribonucleic acid (RNA) isolation and enrichment reagent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market?
The ribonucleic acid (RNA) isolation and enrichment reagents market consists of sales of ribonucleic acid (RNA) extraction kits, magnetic bead-based ribonucleic acid (RNA) isolation reagents, spin column ribonucleic acid (RNA) isolation reagents, and trizol-based ribonucleic acid (RNA) extraction reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Report 2026?
The ribonucleic acid (rna) isolation and enrichment reagent market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) isolation and enrichment reagent industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.04 billion |
| Revenue Forecast In 2030 | $1.57 billion |
| Growth Rate | CAGR of 10.7% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Sample Type, Price Range, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva Sweden AB, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., Tiangen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Illumina Inc., 10x Genomics Inc., Covaris LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |